These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16842893)

  • 1. Nano- and microparticles as adjuvants in vaccine design: success and failure is related to host natural antibodies.
    Sinyakov MS; Dror M; Lublin-Tennenbaum T; Salzberg S; Margel S; Avtalion RR
    Vaccine; 2006 Oct; 24(42-43):6534-41. PubMed ID: 16842893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo.
    Lincopan N; Espíndola NM; Vaz AJ; da Costa MH; Faquim-Mauro E; Carmona-Ribeiro AM
    Vaccine; 2009 Sep; 27(42):5760-71. PubMed ID: 19664738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of protein antigen to microparticulate beta-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations.
    Berner VK; Sura ME; Hunter KW
    Appl Microbiol Biotechnol; 2008 Oct; 80(6):1053-61. PubMed ID: 18677470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral immunization of Carassius auratus with modified recombinant A-layer proteins entrapped in alginate beads.
    Maurice S; Nussinovitch A; Jaffe N; Shoseyov O; Gertler A
    Vaccine; 2004 Dec; 23(4):450-9. PubMed ID: 15530693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical furunculosis vaccines for Atlantic cod (Gadus morhua); vaccine efficacy and antibody responses.
    Lund V; Arnesen JA; Mikkelsen H; Gravningen K; Brown L; Schrøder MB
    Vaccine; 2008 Dec; 26(52):6791-9. PubMed ID: 18951938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
    Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
    Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen coupled with Lewis-x trisaccharides elicits potent immune responses in mice.
    Hsu SC; Tsai TH; Kawasaki H; Chen CH; Plunkett B; Lee RT; Lee YC; Huang SK
    J Allergy Clin Immunol; 2007 Jun; 119(6):1522-8. PubMed ID: 17353042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity.
    Andrianov AK; Marin A; Roberts BE
    Biomacromolecules; 2005; 6(3):1375-9. PubMed ID: 15877355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple whole bacterial antigens in polyvalent vaccine may result in inhibition of specific responses in rainbow trout (Oncorhynchus mykiss).
    Nikoskelainen S; Verho S; Järvinen S; Madetoja J; Wiklund T; Lilius EM
    Fish Shellfish Immunol; 2007 Mar; 22(3):206-17. PubMed ID: 16849036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
    Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvant.
    Ophorst OJ; Radosević K; Klap JM; Sijtsma J; Gillissen G; Mintardjo R; van Ooij MJ; Holterman L; Companjen A; Goudsmit J; Havenga MJ
    Vaccine; 2007 Aug; 25(35):6501-10. PubMed ID: 17646036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of carrier proteins on the immunologic response to haptenic antitetrodotoxin vaccine.
    Xu QH; Zhao XN; Cheng JP; Wei CH; Zhang QH; Rong KT
    Bioconjug Chem; 2006; 17(6):1508-13. PubMed ID: 17105230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance.
    Hunter R; Strickland F; Kézdy F
    J Immunol; 1981 Sep; 127(3):1244-50. PubMed ID: 7264301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The perfect mix: recent progress in adjuvant research.
    Guy B
    Nat Rev Microbiol; 2007 Jul; 5(7):505-17. PubMed ID: 17558426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine immunopotentiators of the future.
    Schijns VE; Degen WG
    Clin Pharmacol Ther; 2007 Dec; 82(6):750-5. PubMed ID: 17914440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
    Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical adjuvants for plasmid DNA vaccines.
    Greenland JR; Letvin NL
    Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.